These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20377868)

  • 1. Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients.
    Bache M; Kappler M; Wichmann H; Rot S; Hahnel A; Greither T; Said HM; Kotzsch M; Würl P; Taubert H; Vordermark D
    BMC Cancer; 2010 Apr; 10():132. PubMed ID: 20377868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients.
    Hahnel A; Wichmann H; Greither T; Kappler M; Würl P; Kotzsch M; Taubert H; Vordermark D; Bache M
    BMC Cancer; 2012 Apr; 12():131. PubMed ID: 22471890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.
    Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC
    BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low HIF-1α and low EGFR mRNA Expression Significantly Associate with Poor Survival in Soft Tissue Sarcoma Patients; the Proteins React Differently.
    Rot S; Taubert H; Bache M; Greither T; Würl P; Holzhausen HJ; Eckert AW; Vordermark D; Kappler M
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse prognostic impact of ErbB2 mRNA and protein expression level in tumors of soft tissue sarcoma patients.
    Wichmann H; Güttler A; Bache M; Taubert H; Vetter M; Würl P; Holzhausen HJ; Eckert AW; Kappler M; Vordermark D
    Strahlenther Onkol; 2014 Oct; 190(10):912-8. PubMed ID: 24715245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance.
    Ruka W; Rutkowski P; Kaminska J; Rysinska A; Steffen J
    Ann Oncol; 2001 Oct; 12(10):1423-32. PubMed ID: 11762815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of osteopontin and HGF/met in adult soft tissue tumors.
    Bramwell VH; Tuck AB; Wilson SM; Stitt LW; Cherian AK; Rorke SC; Al-Katib W; Postenka CO; Chambers AF
    Cancer Biol Ther; 2005 Dec; 4(12):1336-41. PubMed ID: 16258259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of preoperative plasma levels of osteopontin in patients with TNM stage-I of hepatocellular carcinoma.
    Sun J; Xu HM; Zhou HJ; Dong QZ; Zhao Y; Fu LY; Hei ZY; Ye QH; Ren N; Jia HL; Qin LX
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):1-7. PubMed ID: 19593583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancer.
    Ostheimer C; Bache M; Güttler A; Reese T; Vordermark D
    BMC Cancer; 2014 Nov; 14():858. PubMed ID: 25416631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma.
    Kim C; Kim EK; Jung H; Chon HJ; Han JW; Shin KH; Hu H; Kim KS; Choi YD; Kim S; Lee YH; Suh JS; Ahn JB; Chung HC; Noh SH; Rha SY; Kim SH; Kim HS
    BMC Cancer; 2016 Jul; 16():434. PubMed ID: 27393385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival.
    Kappler M; Kotzsch M; Bartel F; Füssel S; Lautenschläger C; Schmidt U; Würl P; Bache M; Schmidt H; Taubert H; Meye A
    Clin Cancer Res; 2003 Mar; 9(3):1098-104. PubMed ID: 12631613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin is a prognostic biomarker in non-small cell lung cancer.
    Kongsgaard A; Boye K; Oijordsbakken M; Lund-Iversen M; Halvorsen AR; Solberg SK; Berge G; Helland A; Brustugun OT; Mælandsmo GM
    BMC Cancer; 2013 Nov; 13():540. PubMed ID: 24215488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patients.
    Köhler T; Würl P; Meye A; Lautenschläger C; Bartel F; Borchert S; Bache M; Schmidt H; Holzhausen HJ; Taubert H
    Anticancer Res; 2002; 22(3):1553-9. PubMed ID: 12168836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
    Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
    Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and Prognostic Performance of Serum Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor Receptor 2, and Osteopontin for Gastrointestinal Cancers.
    Jiang L; Hochwald S; Deng S; Chen Y; Tan C; Zhong Q; Huang H
    Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum thrombomodulin as a metastatic and prognostic marker in soft tissue sarcomas.
    Asanuma K; Nakamura T; Asanuma Y; Kakimoto T; Yada Y; Hagi T; Kita K; Matsumine A; Sudo A
    Cancer Biomark; 2019; 26(2):163-170. PubMed ID: 31356193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High coexpression of CCL2 and CX3CL1 is gender-specifically associated with good prognosis in soft tissue sarcoma patients.
    Kehlen A; Greither T; Wach S; Nolte E; Kappler M; Bache M; Holzhausen HJ; Lautenschläger C; Göbel S; Würl P; Immel UD; Agaimy A; Wullich B; Taubert H
    Int J Cancer; 2014 Nov; 135(9):2096-106. PubMed ID: 24676787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble programmed death-ligand 1 rather than PD-L1 on tumor cells effectively predicts metastasis and prognosis in soft tissue sarcomas.
    Asanuma K; Nakamura T; Hayashi A; Okamoto T; Iino T; Asanuma Y; Hagi T; Kita K; Nakamura K; Sudo A
    Sci Rep; 2020 Jun; 10(1):9077. PubMed ID: 32493964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients.
    Rot S; Taubert H; Bache M; Greither T; Würl P; Eckert AW; Schubert J; Vordermark D; Kappler M
    BMC Cancer; 2011 Oct; 11():429. PubMed ID: 21978106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.